Assessment of beta blockade with propranolol

W. David Hager, Henry J. Pieniaszek, Donald Perrier, Michael Mayersohn, Virginia Goldberger

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Each of seven subjects received on a weekly basis placebo or 10, 20, 40, 80, or 160 mg propanolol orally four times daily. The effect of propranolol on the resting heart rate and the heart rate response to the Valsalva maneuver, tilt, isoproterenol, and maximal exercise were measured. Coefficients of determination were calculated from the individual dose-response curves. The results indicate that the resting heart rate and the tachycardiac response to the Valsalva maneuver and tilt cannot be used to estimate beta blockade. Propranolol concentrations correlated well (mean r2 = 0.80) with the isoproterenol dose ratio minus one, but isoproterenol challenges appear clinically inapplicable. Reduction in maximal exercise tachycardia correlated best with propranolol concentrations (mean r2 = 0.89) but, to the extent that exercise could not be performed, there was no reliable way of clinically documenting beta blockade and only the serum concentration of propranolol was available as an indicator of appropriate therapy.

Original languageEnglish (US)
Pages (from-to)283-290
Number of pages8
JournalClinical Pharmacology and Therapeutics
Volume30
Issue number3
StatePublished - Sep 1981

Fingerprint

Propranolol
Isoproterenol
Valsalva Maneuver
Heart Rate
Tachycardia
Placebos
Serum
Therapeutics

ASJC Scopus subject areas

  • Pharmacology

Cite this

Hager, W. D., Pieniaszek, H. J., Perrier, D., Mayersohn, M., & Goldberger, V. (1981). Assessment of beta blockade with propranolol. Clinical Pharmacology and Therapeutics, 30(3), 283-290.

Assessment of beta blockade with propranolol. / Hager, W. David; Pieniaszek, Henry J.; Perrier, Donald; Mayersohn, Michael; Goldberger, Virginia.

In: Clinical Pharmacology and Therapeutics, Vol. 30, No. 3, 09.1981, p. 283-290.

Research output: Contribution to journalArticle

Hager, WD, Pieniaszek, HJ, Perrier, D, Mayersohn, M & Goldberger, V 1981, 'Assessment of beta blockade with propranolol', Clinical Pharmacology and Therapeutics, vol. 30, no. 3, pp. 283-290.
Hager WD, Pieniaszek HJ, Perrier D, Mayersohn M, Goldberger V. Assessment of beta blockade with propranolol. Clinical Pharmacology and Therapeutics. 1981 Sep;30(3):283-290.
Hager, W. David ; Pieniaszek, Henry J. ; Perrier, Donald ; Mayersohn, Michael ; Goldberger, Virginia. / Assessment of beta blockade with propranolol. In: Clinical Pharmacology and Therapeutics. 1981 ; Vol. 30, No. 3. pp. 283-290.
@article{a6db4cdf9d67446db09b875ad8718b95,
title = "Assessment of beta blockade with propranolol",
abstract = "Each of seven subjects received on a weekly basis placebo or 10, 20, 40, 80, or 160 mg propanolol orally four times daily. The effect of propranolol on the resting heart rate and the heart rate response to the Valsalva maneuver, tilt, isoproterenol, and maximal exercise were measured. Coefficients of determination were calculated from the individual dose-response curves. The results indicate that the resting heart rate and the tachycardiac response to the Valsalva maneuver and tilt cannot be used to estimate beta blockade. Propranolol concentrations correlated well (mean r2 = 0.80) with the isoproterenol dose ratio minus one, but isoproterenol challenges appear clinically inapplicable. Reduction in maximal exercise tachycardia correlated best with propranolol concentrations (mean r2 = 0.89) but, to the extent that exercise could not be performed, there was no reliable way of clinically documenting beta blockade and only the serum concentration of propranolol was available as an indicator of appropriate therapy.",
author = "Hager, {W. David} and Pieniaszek, {Henry J.} and Donald Perrier and Michael Mayersohn and Virginia Goldberger",
year = "1981",
month = "9",
language = "English (US)",
volume = "30",
pages = "283--290",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Assessment of beta blockade with propranolol

AU - Hager, W. David

AU - Pieniaszek, Henry J.

AU - Perrier, Donald

AU - Mayersohn, Michael

AU - Goldberger, Virginia

PY - 1981/9

Y1 - 1981/9

N2 - Each of seven subjects received on a weekly basis placebo or 10, 20, 40, 80, or 160 mg propanolol orally four times daily. The effect of propranolol on the resting heart rate and the heart rate response to the Valsalva maneuver, tilt, isoproterenol, and maximal exercise were measured. Coefficients of determination were calculated from the individual dose-response curves. The results indicate that the resting heart rate and the tachycardiac response to the Valsalva maneuver and tilt cannot be used to estimate beta blockade. Propranolol concentrations correlated well (mean r2 = 0.80) with the isoproterenol dose ratio minus one, but isoproterenol challenges appear clinically inapplicable. Reduction in maximal exercise tachycardia correlated best with propranolol concentrations (mean r2 = 0.89) but, to the extent that exercise could not be performed, there was no reliable way of clinically documenting beta blockade and only the serum concentration of propranolol was available as an indicator of appropriate therapy.

AB - Each of seven subjects received on a weekly basis placebo or 10, 20, 40, 80, or 160 mg propanolol orally four times daily. The effect of propranolol on the resting heart rate and the heart rate response to the Valsalva maneuver, tilt, isoproterenol, and maximal exercise were measured. Coefficients of determination were calculated from the individual dose-response curves. The results indicate that the resting heart rate and the tachycardiac response to the Valsalva maneuver and tilt cannot be used to estimate beta blockade. Propranolol concentrations correlated well (mean r2 = 0.80) with the isoproterenol dose ratio minus one, but isoproterenol challenges appear clinically inapplicable. Reduction in maximal exercise tachycardia correlated best with propranolol concentrations (mean r2 = 0.89) but, to the extent that exercise could not be performed, there was no reliable way of clinically documenting beta blockade and only the serum concentration of propranolol was available as an indicator of appropriate therapy.

UR - http://www.scopus.com/inward/record.url?scp=0019442342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019442342&partnerID=8YFLogxK

M3 - Article

C2 - 6115730

AN - SCOPUS:0019442342

VL - 30

SP - 283

EP - 290

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 3

ER -